Formulating a skincare product is an exercise in controlled compromise. Every active ingredient has a pH range where it is stable, soluble, and bioavailable. Outside that range, it degrades, precipitates, or becomes inactive. With one active ingredient, this is manageable. With nine, it becomes a chemistry problem that most labs simply don't solve — they avoid it by keeping their formulas simple.
Consider GHK-Cu. The copper peptide complex is stable between pH 5.5 and 6.5. Below pH 5.0, the copper ion dissociates from the peptide — you lose the signalling function entirely. Above pH 7.0, copper hydroxide precipitates form, turning the solution cloudy and useless. The window is one pH unit wide. Miss it, and your copper peptide is gone.
Now consider niacinamide. It is stable between pH 5.0 and 7.0. Below 4.5, it hydrolyses into nicotinic acid — which causes the flushing and irritation that some people associate with niacinamide products. This is not a niacinamide reaction. It is a formulation failure. A properly buffered formula keeps niacinamide in its active form throughout the product's lifecycle.
Why We Excluded Vitamin C
L-ascorbic acid — the active form of vitamin C — requires a pH below 3.5 to remain stable and penetrate the stratum corneum. At pH 5.5, it is ionised and cannot cross the lipid barrier. At pH 6.0, it oxidises within hours in an aqueous environment. This is not a judgement on vitamin C as a molecule. It is a simple statement of chemical incompatibility. Including vitamin C in a formula that also contains GHK-Cu, niacinamide, and ergothioneine would require a pH so low that every other active would degrade. The choice was clear: keep the network intact, or add a molecule that destroys it.
The Buffer System
A buffer is not just a pH adjuster. It is a chemical system that resists pH change when acids or bases are introduced — including the acids and bases that actives generate as they degrade. Without a properly designed buffer, the formula's pH drifts over time. Each degradation product shifts the equilibrium slightly. Over months, the pH can move far enough to destabilise another active, which then degrades faster, which shifts the pH further. This is a cascade failure, and it is the leading cause of potency loss in multi-active formulations.
At NeolabCare, the buffer system is designed for the specific degradation kinetics of all nine actives. Stability testing at 25°C and 40°C confirms that pH remains within the target range across the product's use period. This is not a one-time formulation decision — it is tested on every batch. Made-to-order production provides a secondary safeguard: the product spends seven days between compounding and delivery, not eighteen months on a shelf. Even a perfectly buffered formula experiences slow pH drift at room temperature. The shorter the timeline, the less drift occurs. Freshness is not just about potency. It is about chemical integrity.